Urodynamic Equipment And Consumables Market Analysis By Type (Uroflowmetry Equipment, Cystometer, Ambulatory Systems, Electromyographs, Video Urodynamic Systems, Catheters, Pumps & Transducer Sets), And Segment Forecasts, 2018 - 2025

Industry Insights

The global urodynamic equipment and consumables market size was estimated at USD 189.15 million in 2016, and is anticipated to grow at a CAGR of 6.32% throughout the forecast period. The market is predominantly driven by rising prevalence of diseases such as benign prostatic hypertrophy, bladder cancer, neurogenic bladder dysfunction, overactive bladder, and others.

According to World Health Organization, globally, 330,000 new cases of bladder cancer are diagnosed every year. In addition, as per National Association for Incontinence, 200 million people globally are suffering from urinary incontinence, which raises the clinical urgency to adopt urodynamic equipment.

U.S. urodynamic equipment and consumables market by type, 2014 - 2025 (USD Million)

Increase in healthcare initiatives being undertaken to create awareness about urological problems and available diagnostics &treatment is anticipated to broaden growth potential. For instance, “Let’s Talk and Think About Continence” (Japan), “Continence Awareness Week” (Continence Foundation, UK), and others.

As a result of these initiatives, an increasing number of people suffering from urinary incontinence have been able to overcome social stigma associated it and have begun consulting physicians. This has thereby fueled demand for these medical devices.

Technological advancements, such as doppler ultrasound video urodynamic, condom catheter, intravesical prostatic protrusion, and penile cuff, are also amongst major growth contributors. In addition, continuous product approvals, proliferating network of testing centers, and availability of medical reimbursement for urological preliminary tests are also responsible for propelling the market.

Type Insights

In 2016, uroflowmetry segment dominated the type segment with a share of over 30.0%. The substantial share registered by this segment is a result of extensive usage of uroflowmetry in diagnosis of urinary blockage, benign prostatic hypertrophy, bladder cancer, neurogenic bladder, bladder dysfunction, and prostate cancer.

Due to innovative technology, uroflowmetry products give accurate results. As a result, there is a significant increase in adoption rates amongst physicians. In addition, increasing global presence of manufacturers owing to expanding distribution network results in greater access to these products, which is also a key contributing factor.

Ambulatory systems are expected to exhibit a strong CAGR of over 7.0% throughout the forecast period. The exponential growth of this segment can be attributed to the associated benefits of ambulatory systems. These benefits include greater portability, affordability, and real-time diagnosis to yield highly accurate results.

Electromyographs (EMGs) are anticipated to grow moderately during the forecast period. These devices find application in a wide range of disorders, such as muscular dystrophy, myasthenia gravis, radiculopathies, carpal tunnel syndrome, amyotrophic lateral sclerosis, sciatica, and many others. EMG has various diagnostic and research applications. EMG is also used to avoid postoperative residual curarization (PORC) and conduct nerve conduction studies.

Regional Insights

In 2016, North America accounted for the largest share of over 37.0% amongst all regions. This can be attributed to rising prevalence of target diseases. The dominant share is also a consequence of high adoption rate of urodynamic products in various diagnostic, healthcare, & pharmaceutical centers and growing preference of urogynecologists & urologists for urodynamic tests.

Global urodynamic equipment and consumables market share by region, 2016 (%)

Asia Pacific is expected to witness exponential CAGR of over 6.0% throughout the forecast period. This growth can be attributed to rise in prevalence of urological diseases, growing disposable income, and unmet patient needs. Rapid rise in geriatric population, which has greater vulnerability to urological dysfunctions, is expected to further contribute to the market growth across this region.

Another factor expected to contribute to growth in Asia Pacific is increasing availability and usage in diagnostic centers. In addition, rapid economic growth in developing countries such as India, Singapore, China, and others is also anticipated to boost product penetration.

Competitive Insights

The highly competitive environment is a result of key players extensively deploying sustainability strategies. These include Boston Scientific Corporation; LABORIE; Verathon, Inc.; and others. These companies are consistently striving to implement strategies such as mergers & acquisitions, new product development initiatives, and geographical expansion.

For instance, in March 2017, LABORIE acquired ANDROMEDA Medizinische Systems GmbH to expand its product offerings in Europe. Similarly, in November 2016, Boston Scientific Corporation launched Dakota Nitinol Stone Retrieval Device with OpenSure Handle to expand its product portfolio.

Report Scope

Segments covered in the report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the industry trends in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global urodynamic equipment and consumables market on the basis of type and region: 

• Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Uroflowmetry Equipment

  • Cystometry

  • Ambulatory Urodynamic Systems

  • Electromyographs

  • Video Urodynamic Systems

  • Urodynamic Consumables

    • Urodynamic Catheters

    • Urodynamic Pumps and Transducer Sets

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa